Our group’s research centers on neuroimaging in aging and neurodegenerative diseases. Our four areas are:
- Medial temporal lobe (MTL) subregions are hotspots for neurodegenerative diseases and imaging measures of these regions might therefore be good biomarkers. We focus on two subareas:
- The development of methods to accurately measure MTL subregions: going from ex vivo validation, to the development of manual segmentation protocols and the incorporation in automated algorithms.
- The study of imaging measures of MTL subregions to better understand disease mechanisms and improve diagnosis and prognosis of neurodegenerative diseases.
- Postmortem study of neurodegenerative diseases: As most neurodegenerative pathologies cannot be assessed during life or only imperfectly, postmortem imaging and the study of neurodegenerative pathologies can teach us important lessons.
- Alzheimer’s disease mimics: There are several groups that present with amnestic syndrome, like Alzheimer’s patients, but have a different etiology. We aim to characterize these patient groups and better understand their etiology and prognosis.
Impact
These different lines of research help elucidate disease mechanisms of neurodegenerative diseases as well as contribute to the development of sensitive biomarkers for diagnosis, prognosis and to track treatment responses in clinical trials. Our ultimate goal is to contribute to curing all neurodegenerative diseases.
